Cytokine inhibition in the treatment of COPD

References

• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: NHLBI/WHO Workshop ReportBethesda (MD)National Heart, Lung and Blood Institute2001
   Google Scholar
• ChungKFAdcockIMMultifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destructionEur Respir J2008311334135618515558
   PubMed Web of Science ®Google Scholar
• BurrowsBKnudsonRJClineMGLebowitzMDQuantitative relationships between cigarette smoking and ventilatory functionAm Rev Respir Dis1977115195205842934
   PubMed Web of Science ®Google Scholar
• SalviSSBarnesPJChronic obstructive pulmonary disease in non-smokersLancet200937473374319716966
   PubMed Web of Science ®Google Scholar
• Di StefanoACaramoriGRicciardoloFLCapelliAAdcockIMDonnerCFCellular and molecular mechanisms in chronic obstructive pulmonary disease: an overviewClin Exp Allergy2004341156116715298554
   PubMed Web of Science ®Google Scholar
• CaramoriGPanditAPapiAIs there a difference between chronic airway inflammation in chronic severe asthma and chronic obstructive pulmonary disease?Curr Opin Allergy Clin Immunol20055778315643348
   PubMed Web of Science ®Google Scholar
• CaramoriGCasolariPGiuffrèSBarczykAAdcockIPapiACOPD pathology in the small airwaysPanminerva Med201153517021346704
   PubMed Web of Science ®Google Scholar
• HoggJCTimensWThe pathology of chronic obstructive pulmonary diseaseAnnu Rev Pathol2009443545918954287
   PubMed Web of Science ®Google Scholar
• HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med20043502645265315215480
   PubMed Web of Science ®Google Scholar
• GalbánCJHanMKBoesJLComputed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progressionNat Med2012181711171523042237
   PubMed Web of Science ®Google Scholar
• SniderGLChronic obstructive pulmonary disease: a continuing challengeAm Rev Respir Dis19861339429443706907
   PubMed Web of Science ®Google Scholar
• VestboJHoggJCConvergence of the epidemiology and pathology of COPDThorax200661868816227325
   PubMed Web of Science ®Google Scholar
• de MarcoRAccordiniSCerveriIIncidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegmAm J Respir Crit Care Med2007175323917008642
   PubMed Web of Science ®Google Scholar
• CaramoriGDi GregorioCCarlstedtIMucin expression in peripheral airways of patients with chronic obstructive pulmonary diseaseHistopathology20044547748415500651
   PubMed Web of Science ®Google Scholar
• CaramoriGCasolariPDi GregorioCMUC5AC expression is increased in bronchial submucosal glands of stable COPD patientsHistopathology20095532133119723147
   PubMed Web of Science ®Google Scholar
• RoseMCVoynowJARespiratory tract mucin genes and mucin glycoproteins in health and diseasePhysiol Rev20068624527816371599
   PubMed Web of Science ®Google Scholar
• AikawaTShimuraSSasakiHTakishimaTYaegashiHTakahashiTMorphometric analysis of intraluminal mucus in airways in chronic obstructive pulmonary diseaseAm Rev Respir Dis19891404774822764384
   PubMed Web of Science ®Google Scholar
• BarnesPJCelliBRSystemic manifestations and comorbidities in COPDEur Respir J2009331165118519407051
   PubMed Web of Science ®Google Scholar
• CaramoriGAdcockIMPapiAClinical definition of COPD exacerbations and classification of their severitySouth Med J200910227728219204646
   PubMed Web of Science ®Google Scholar
• BarnesPJNew anti-inflammatory targets for chronic obstructive pulmonary diseaseNat Rev Drug Discov20131254355923977698
   PubMed Web of Science ®Google Scholar
• PapiABellettatoCMBraccioniFInfections and airway inflammation in chronic obstructive pulmonary disease severe exacerbationsAm J Respir Crit Care Med20061731114112116484677
   PubMed Web of Science ®Google Scholar
• BarczykAPierzchalaWKonOMCosioBAdcockIMBarnesPJCytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary diseaseJ Allergy Clin Immunol20061171484149216751017
   PubMed Web of Science ®Google Scholar
• PaatsMSBergenIMHoogstedenHCvan der EerdenMMHendriksRWSystemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPDEur Respir J20124033033722183488
   PubMed Web of Science ®Google Scholar
• Di StefanoACaramoriGGnemmiIT helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patientsClin Exp Immunol200915731632419604272
   PubMed Web of Science ®Google Scholar
• CaramoriGDi StefanoACasolariPChemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary diseaseCurr Med Chem2013204317434924059236
   PubMed Web of Science ®Google Scholar
• BarnesPJThe cytokine network in chronic obstructive pulmonary diseaseAm J Respir Cell Mol Biol20094163163819717810
   PubMed Web of Science ®Google Scholar
• BarnesPJMediators of chronic obstructive pulmonary diseasePharmacol Rev20045651554815602009
   PubMed Web of Science ®Google Scholar
• CaramoriGCasolariPAdcockIRole of transcription factors in the pathogenesis of asthma and COPDCell Commun Adhes201320214023472830
   PubMed Web of Science ®Google Scholar
• Di StefanoACaramoriGBarczykAInnate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPDThorax Epub1152014
   Web of Science ®Google Scholar
• FreemanCMMartinezFJHanMKLung CD8+ T cells in COPD have increased expression of bacterial TLRsRespir Res2013141323374856
   PubMed Web of Science ®Google Scholar
• BosséYUpdates on the COPD gene listInt J Chron Obstruct Pulmon Dis2012760763123055711
   PubMed Web of Science ®Google Scholar
• LordPCWilmothLMMizelSBMcCallCEExpression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytesJ Clin Invest199187131213212010544
   PubMed Web of Science ®Google Scholar
• RosenwasserLJBiologic activities of IL-1 and its role in human diseaseJ Allergy Clin Immunol19981023443509768571
   PubMed Web of Science ®Google Scholar
• ChenCJKonoHGolenbockDReedGAkiraGRockKLIdentification of a key pathway required for the sterile inflammatory response triggered by dying cellsNat Med20071385185617572686
   PubMed Web of Science ®Google Scholar
• ArendWPInterleukin 1 receptor antagonist: a new member of the interleukin 1 familyJ Clin Invest199188144514511834696
   PubMed Web of Science ®Google Scholar
• BotelhoFMBauerCMFinchDIL-1α/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in micePLoS One20116e2845722163019
   PubMed Web of Science ®Google Scholar
• FerhaniNLetuveSKozhichAExpression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201018191792720133931
   PubMed Web of Science ®Google Scholar
• PauwelsNSBrackeKRDupontLLRole of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPDEur Respir J2011381019102821622588
   PubMed Web of Science ®Google Scholar
• SinghBAroraSKhannaVAssociation of severity of COPD with IgE and interleukin-1 betaMonaldi Arch Chest Dis201073868720949775
   PubMedGoogle Scholar
• ZeidelABeilinBYardeniIImmune response in asymptomatic smokersActa Anaesthesiol Scand20024695996412190796
   PubMed Web of Science ®Google Scholar
• BotelhoFMNikotaJKBauerCMCigarette smoke-induced accumulation of lung dendritic cells is interleukin-1α-dependent in miceRespir Res2012138122992200
   PubMed Web of Science ®Google Scholar
• ChurgAZhouSWangXWangRWrightJLThe role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodelingAm J Respir Cell Mol Biol20094048249018931327
   PubMed Web of Science ®Google Scholar
• NovartisSafety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) Patients Available from: http://clinicaltrials.gov/show/NCT0581945. NLM identifier: NCT0581945Accessed February 21, 2014
   Google Scholar
• MedImmune LLCA to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease (SPRING) Available from: http://clinicaltrials.gov/ct2/show/NCT1448850. NLM identifier: NCT1448850Accessed February 20, 2014
   Google Scholar
• BarcelóBPonsJFusterAIntracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary diseaseClin Exp Immunol200614547447916907916
   PubMed Web of Science ®Google Scholar
• LiuZYaoWZChenYDingYLRole of interleukin-9 in the pathogenesis of chronic obstructive pulmonary diseaseBeijing Da Xue Xue Bao200436403406 Chinese15303135
   PubMedGoogle Scholar
• MillerMRamsdellJFriedmanPJChoJYRenvallMBroideDHComputed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: eotaxin-1 is associated with bronchodilator response and extent of emphysemaJ Allergy Clin Immunol20071201118112517983873
   PubMed Web of Science ®Google Scholar
• PanznerPLafitteJJTsicopoulosAHamidQTulicMKMarked up-regulation of T lymphocytes and expression of interleukin-9 in bronchial biopsies from patients with chronic bronchitis with obstructionChest20031241909191514605067
   PubMed Web of Science ®Google Scholar
• MiottoDRuggieriMPBoschettoPInterleukin-13 and -4 expression in the central airways of smokers with chronic bronchitisEur Respir J20032260260814582911
   PubMed Web of Science ®Google Scholar
• ZhuJQiuYSMajumdarSExacerbations of bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractantsAm J Respir Crit Care Med200116410911611435248
   PubMed Web of Science ®Google Scholar
• ZhuJQiuYValobraMPlasma cells and IL-4 in chronic bronchitis and chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20071751125113317322111
   PubMed Web of Science ®Google Scholar
• BafadhelMSahaSSivaRSputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPDRespiration20097825626219478474
   PubMed Web of Science ®Google Scholar
• BafadhelMMcCormickMSahaSProfiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary diseaseRespiration201283364421912093
   PubMed Web of Science ®Google Scholar
• RohdeGGevaertPHoltappelsGSoluble interleukin-5 receptor alpha is increased in acute exacerbation of chronic obstructive pulmonary diseaseInt Arch Allergy Immunol2004135546115286446
   PubMed Web of Science ®Google Scholar
• SaettaMDi StefanoAMaestrelliPAirway eosinophilia and expression of interleukin-5 protein in asthma and exacerbations of chronic bronchitisClin Exp Allergy1996267667748842549
   PubMed Web of Science ®Google Scholar
• ProfitaMChiapparaGMirabellaFEffect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPDThorax20035857357912832668
   PubMed Web of Science ®Google Scholar
• LaanMBozinovskiSAndersonGPCigarette smoke inhibits lipopolysaccharide-induced production of inflammatory cytokines by suppressing the activation of activator protein-1 in bronchial epithelial cellsJ Immunol20041734164417015356167
   PubMed Web of Science ®Google Scholar
• KuboSKobayashiMMasunagaYCytokine and chemokine expression in cigarette smoke-induced lung injury in guinea pigsEur Respir J200526993100116319327
   PubMed Web of Science ®Google Scholar
• ShuklaMKumarPMishraVCarryover of cigarette smoke effects on hematopoietic cytokines to F1 mouse littersMol Immunol2011481809181721636132
   PubMed Web of Science ®Google Scholar
• van der DeenMTimensWTimmer-BosschaHReduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient miceRespir Res200784917617921
   PubMed Web of Science ®Google Scholar
• BozinovskiSJonesJEVlahosRHamiltonJAAndersonGPGranulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 in vivoJ Biol Chem2002277428084281412208854
   PubMed Web of Science ®Google Scholar
• PuljicRBenediktusEPlater-ZyberkCLipopolysaccharide-induced lung inflammation is inhibited by neutralization of GM-CSFEur J Pharmacol200755723023517174948
   PubMed Web of Science ®Google Scholar
• VlahosRBozinovskiSHamiltonJAAndersonGPTherapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF)Pharmacol Ther200611210611516716406
   PubMed Web of Science ®Google Scholar
• VlahosRBozinovskiSChanSPNeutralizing granulocyte/macrophage colony-stimulating factor inhibits cigarette smoke-induced lung inflammationAm J Respir Crit Care Med2010182344020203243
   PubMed Web of Science ®Google Scholar
• FreemanCMHanMKMartinezFJCytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15J Immunol20101846504651320427767
   PubMed Web of Science ®Google Scholar
• SahaSDoeCMistryVGranulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPDThorax20096467167619213775
   PubMed Web of Science ®Google Scholar
• ZioraDDworniczakSKaczmarczykGJastrzebskiDKrzywieckiAKozielskiJCorrelation of exhaled nitric oxide with nitrogen oxides and selected cytokines in induced sputum of chronic obstructive pulmonary disease patientsJ Physiol Pharmacol200758 Suppl 579179918204193
   PubMed Web of Science ®Google Scholar
• CosioMGSaettaMAgustiAImmunologic aspects of chronic obstructive pulmonary diseaseN Engl J Med20093602445245419494220
   PubMed Web of Science ®Google Scholar
• KirkhamPACaramoriGCasolariPOxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201118479680221965015
   PubMed Web of Science ®Google Scholar
• KishimotoTThe biology of interleukin-6Blood1989741102473791
   PubMed Web of Science ®Google Scholar
• KolsumURoyKStarkeyCThe repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one yearInt J Chron Obstruct Pulmon Dis J20094149156
   PubMedGoogle Scholar
• GanWQManSFSenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax20045957458015223864
   PubMed Web of Science ®Google Scholar
• CelliBRLocantoreNYatesJInflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20121851065107222427534
   PubMed Web of Science ®Google Scholar
• FerrariRTanniSECaramLMCorrêaCCorrêaCRGodoyIThree-year follow-up of interleukin 6 and C-reactive protein in chronic obstructive pulmonary diseaseRespir Res2013142423425215
   PubMed Web of Science ®Google Scholar
• KellyEOwenCAPinto-PlataVCelliBRThe role of systemic inflammatory biomarkers to predict mortality in chronic obstructive pulmonary diseaseExpert Rev Respir Med20137576423362815
   PubMed Web of Science ®Google Scholar
• LuYFengLFengLNyuntMSYapKBNgTPSystemic inflammation, depression and obstructive pulmonary function: a population-based studyRespir Res2013145323676005
   PubMed Web of Science ®Google Scholar
• RöpckeSHolzOLauerGRepeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputumPLoS One20127e4620723056262
   PubMed Web of Science ®Google Scholar
• VanfleterenLESpruitMAGroenenMClusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201318772873523392440
   PubMed Web of Science ®Google Scholar
• Grubek-JaworskaHPaplinskaMHermanowicz-SalamonJIL-6 and IL-13 in induced sputum of COPD and asthma patients: correlation with respiratory testsRespiration20128410110722311051
   PubMed Web of Science ®Google Scholar
• ManeechotesuwanKKasetsinsombatKWongkajornsilpABarnesPJDecreased indoleamine 2,3-dioxygenase activity and IL-10/IL-17A ratio in patients with COPDThorax20136833033723255616
   PubMed Web of Science ®Google Scholar
• YaoXHuangJZhongHTargeting interleukin-6 in inflammatory autoimmune diseases and cancersPharmacol Ther201414112513924076269
   PubMed Web of Science ®Google Scholar
• MoyMLTeylanMWestonNAGagnonDRDanilackVAGarshickEDaily step count is associated with plasma CRP and IL-6 in a US cohort with COPDChest Epub1032013
   Web of Science ®Google Scholar
• MoonPDChoiIHKimHMNaringenin suppresses the production of thymic stromal lymphopoietin through the blockade of RIP2 and caspase-1 signal cascade in mast cellsEur J Pharmacol201167112813221963452
   PubMed Web of Science ®Google Scholar
• MoonPDChoiIHKimHMBerberine inhibits the production of thymic stromal lymphopoietin by the blockade of caspase-1/NF-κB pathway in mast cellsInt Immunopharmacol2011111954195921856447
   PubMed Web of Science ®Google Scholar
• MoonPDKimHMThymic stromal lymphopoietin is expressed and produced by caspase-1/NF-κB pathway in mast cellsCytokine20115423924321463955
   PubMed Web of Science ®Google Scholar
• MoonPDChoiIHKimHMEpigallocatechin-3-O-gallate inhibits the production of thymic stromal lymphopoietin by the blockade of caspase-1/NF-κB pathway in mast cellsAmino Acids2012422513251921833768
   PubMed Web of Science ®Google Scholar
• AllakhverdiZComeauMRJessupHKThymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cellsJ Exp Med200720425325817242164
   PubMed Web of Science ®Google Scholar
• LeeHCZieglerSFInducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaBProc Natl Acad Sci U S A200710491491917213320
   PubMed Web of Science ®Google Scholar
• ShanLRedhuNSSalehAHalaykoAJChakirJGounniASThymic stromal lymphopoietin receptor-mediated IL-6 and CC/CXC chemokines expression in human airway smooth muscle cells: role of MAPKs (ERK1/2, p38, and JNK) and STAT3 pathwaysJ Immunol20101847134714320483734
   PubMed Web of Science ®Google Scholar
• SmelterDFSathishVThompsonMAPabelickCMVassalloRPrakashYSThymic stromal lymphopoietin in cigarette smoke-exposed human airway smooth muscleJ Immunol20101853035304020660708
   PubMed Web of Science ®Google Scholar
• AllakhverdiZComeauMRJessupHKDelespesseGThymic stromal lymphopoietin as a mediator of crosstalk between bronchial smooth muscles and mast cellsJ Allergy Clin Immunol2009123958960. e219348931
   PubMed Web of Science ®Google Scholar
• KabataHMoroKFukunagaKThymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammationNat Commun201325267524157859
   PubMed Web of Science ®Google Scholar
• HanHHeadleyMBXuWComeauMRZhouBZieglerSFThymic stromal lymphopoietin amplifies the differentiation of alternatively activated macrophagesJ Immunol201319090491223275605
   PubMed Web of Science ®Google Scholar
• YingSO’ConnorBRatoffJExpression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary diseaseJ Immunol20081812790279818684970
   PubMed Web of Science ®Google Scholar
• ZhangKShanLRahmanMSUnruhHHalaykoAJGounniASConstitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary diseaseAm J Physiol Lung Cell Mol Physiol2007293L375L38217513456
   PubMed Web of Science ®Google Scholar
• ShiLLeuSWXuFLocal blockade of TSLP receptor alleviated allergic disease by regulating airway dendritic cellsClin Immunol200812920221018757241
   PubMed Web of Science ®Google Scholar
• KeatingsVMCollinsPDScottDMBarnesPJDifferences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthmaAm J Respir Crit Care Med19961535305348564092
   PubMed Web of Science ®Google Scholar
• YamamotoCYonedaTYoshikawaMAirway inflammation in COPD assessed by sputum levels of interleukin-8Chest19971125055109266891
   PubMed Web of Science ®Google Scholar
• YangDCorvalanJRWangPRoyCMDavisCGFully human anti-interleukin-8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease statesJ Leukoc Biol19996640141010496309
   PubMed Web of Science ®Google Scholar
• BeehKMKornmannOBuhlRCulpittSVGiembyczMABarnesPJNeutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4Chest20031231240124712684317
   PubMed Web of Science ®Google Scholar
• HillATBayleyDStockleyRAThe interrelationship of sputum inflammatory markers in patients with chronic bronchitisAm J Respir Crit Care Med199916089389810471615
   PubMed Web of Science ®Google Scholar
• KaurMSinghDNeutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2J Pharmacol Exp Ther201334717318023912333
   PubMed Web of Science ®Google Scholar
• WoolhouseISBayleyDLStockleyRASputum chemotactic activity in chronic obstructive pulmonary disease: effect of α1-antitrypsin deficiency and the role of leukotriene B4 and interleukin 8Thorax20025770971412149532
   PubMed Web of Science ®Google Scholar
• TaninoMBetsuyakuTTakeyabuKYamagushiEMiyamotoKNishimuraMIncreased levels of IL-8 in BAL fluid from smokers susceptible to pulmonary emphysemaThorax20025740541111978916
   PubMed Web of Science ®Google Scholar
• SolerNEwigSTorresAFilellaXGonzalezJZaubetAAirway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary diseaseEur Respir J1999141015102210596683
   PubMed Web of Science ®Google Scholar
• Di StefanoACaramoriGGnemmiIAssociation of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPDThorax20096496897519703829
   PubMed Web of Science ®Google Scholar
• de BoerWISontJKvan SchadewijkAStolkJvan KriekenJHHiem-straPSMonocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPDJ Pathol200019061962610727989
   PubMed Web of Science ®Google Scholar
• TomakiMSugiuraHKoaraiADecreased expression of antioxidant enzymes and increased expression of chemokines in COPDPulm Pharm Ther200720596605
   PubMed Web of Science ®Google Scholar
• FukeSBetsuyacuTNasuharaYMorikawaTKatohHNishimuraMChemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary diseaseAm J Respir Cell Mol Biol20043140541215220136
   PubMed Web of Science ®Google Scholar
• MahlerDAHuangSTabriziMBellGMEfficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPDChest200412692693415364775
   PubMed Web of Science ®Google Scholar
• MagnussenHHolzOWatzHSafety and efficacy of SCH527123, a novel CXCR2 antagonist, in patients with COPDEur Resp J201036 Suppl38S
   Google Scholar
• KirstenAMBalintBCullbergMThe safety and tolerability of twice-daily oral doses of AZD5069, a novel CXCR2 antagonist, in patients with moderate-to-severe COPDEur Resp J201238 Suppl546S
   Google Scholar
• KollsJKLindenAInterleukin-17 family members and inflammationImmunity20042146747615485625
   PubMed Web of Science ®Google Scholar
• HoeveMASavageNDDe BoerTDivergent effects of IL-12 and IL-23 on the production of IL-17 by human T cellsEur J Immunol20063666167016482511
   PubMed Web of Science ®Google Scholar
• KoenenHJSmeetsRLVinkPMvan RijssenEBootsAMJoostenIHuman CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cellsBlood20081122340235218617638
   PubMed Web of Science ®Google Scholar
• MaddurMSMiossecPKaveriSVBayryJTh17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategiesAm J Pathol201218181822640807
   PubMed Web of Science ®Google Scholar
• JonesCEChanKInterleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-α, and granulocyte-colony-stimulating factor by human airway epithelial cellsAm J Respir Cell Mol Biol20022674875312034575
   PubMed Web of Science ®Google Scholar
• RahmanMSYangJShanLYIL-17R activation of human airway smooth muscle cells induces CXCL-8 production via a transcriptional-dependent mechanismClin Immunol200511526827615893694
   PubMed Web of Science ®Google Scholar
• VanaudenaerdeBMWuytsWADupontLJVan RaemdonckDEDemedtsMMVerledenGMInterleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndromeJ Heart Lung Transplant2003221280128314585390
   PubMed Web of Science ®Google Scholar
• ChenYThaiPZhaoYHHoYSDeSouzaMMWuRStimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loopJ Biol Chem2003278170361704312624114
   PubMed Web of Science ®Google Scholar
• KudoMMeltonACChenCIL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contractionNat Med20121854755422388091
   PubMed Web of Science ®Google Scholar
• ZhangLChengZLiuWWuKExpression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patientsCOPD20131045946523537276
   PubMedGoogle Scholar
• ZhangXZhengHZhangHIncreased interleukin (IL)-8 and decreased IL-17 production in chronic obstructive pulmonary disease (COPD) provoked by cigarette smokeCytokine20115671772521996014
   PubMed Web of Science ®Google Scholar
• DoeCBafadhelMSiddiquiSExpression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPDChest20101381140114720538817
   PubMed Web of Science ®Google Scholar
• EustaceASmythLJMitchellLWilliamsonKPlumbJSinghDIdentification of cells expressing IL-17A and IL-17F in the lungs of patients with COPDChest20111391089110020864612
   PubMed Web of Science ®Google Scholar
• ShenNWangJZhaoMPeiFHeBAnti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed miceInhal Toxicol20112321221821456954
   PubMed Web of Science ®Google Scholar
• McKinleyLAlcornJFPetersonATH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in miceJ Immunol20081814089409718768865
   PubMed Web of Science ®Google Scholar
• ChangYAl-AlwanLAudusseauSGenetic deletion of IL-17A reduces cigarette smoke-induced inflammation and alveolar type II cell apoptosisAm J Physiol Lung Cell Mol Physiol2014306L132L14324097560
   PubMed Web of Science ®Google Scholar
• ChenKPociaskDAMcAleerJPIL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smokePLoS One20116e2033321647421
   PubMed Web of Science ®Google Scholar
• KurimotoEMiyaharaNKanehiroAIL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in miceRespir Res201314523331548
   PubMed Web of Science ®Google Scholar
• PinartMZhangMLiFIL-17A modulates oxidant stress-induced airway hyperresponsiveness but not emphysemaPLoS One20138e5845223505509
   PubMed Web of Science ®Google Scholar
• BusseWWHolgateSKerwinERandomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthmaAm J Respir Crit Care Med20131881294130224200404
   PubMed Web of Science ®Google Scholar
• TorigoeKUshioSOkuraTPurification and characterization of the human interleukin-18 receptorJ Biol Chem199727225737257429325300
   PubMed Web of Science ®Google Scholar
• BornTLThomassenEBirdTASimsJECloning of a novel receptor subunit, AcPL, required for interleukin-18 signalingJ Biol Chem199827329445294509792649
   PubMed Web of Science ®Google Scholar
• SmithDEThe biological paths of IL-1 family members IL-18 and IL-33J Leukoc Biol20118938339220952658
   PubMed Web of Science ®Google Scholar
• KawayamaTOkamotoMImaokaHKatoSYoungHAHoshinoTInterleukin-18 in pulmonary inflammatory diseasesJ Interferon Cytokine Res20123244344922900713
   PubMed Web of Science ®Google Scholar
• LamkanfiMWalleLVKannegantiTDDeregulated inflammasome signaling in diseaseImmunol Rev201124316317321884175
   PubMed Web of Science ®Google Scholar
• Van de VeerdonkFLNeteaMGDinarelloCAJoostenLAInflammasome activation and IL-1β and IL-18 processing during infectionTrends Immunol20113211011621333600
   PubMed Web of Science ®Google Scholar
• NakajimaTOwenCAInterleukin-18: the master regulator driving destructive and remodeling processes in the lungs of patients with chronic obstructive pulmonary disease?Am J Respir Crit Care Med20121851137113922661518
   PubMed Web of Science ®Google Scholar
• EltomSStevensonCSRastrickJP2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smokePLoS One20116e2409
   Web of Science ®Google Scholar
• KangMJHomerRJGalloAIL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammationJ Immunol20071781948195917237446
   PubMed Web of Science ®Google Scholar
• MatsuuraHHartlDKangMJRole of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysemaAm J Respir Cell Mol Biol20114477778620656949
   PubMed Web of Science ®Google Scholar
• KratzerASalysJNold-PetryCRole of IL-18 in second hand smoke-induced emphysemaAm J Respir Cell Mol Biol20134872573223392573
   PubMed Web of Science ®Google Scholar
• KratzerAChuHWSalysJEndothelial cell adhesion molecule CD146: implications for its role in the pathogenesis of COPDJ Pathol201323038839823649916
   PubMed Web of Science ®Google Scholar
• KangMJChoiJMKimBHIL-18 induces emphysema and airway and vascular remodeling via IFN-γ, IL-17A, and IL-13Am J Respir Crit Care Med20121851205121722383501
   PubMed Web of Science ®Google Scholar
• ImaokaHHoshinoTTakeiSInterleukin-18 production and pulmonary function in COPDEur Respir J20083128729717989120
   PubMed Web of Science ®Google Scholar
• PetersenAMPenkowaMIversenMElevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary diseaseLung200718516117117436040
   PubMed Web of Science ®Google Scholar
• RovinaNDimaEGerassimouCKollintzaAGratziouCRoussosCInterleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary diseaseRespir Med20091031056106219208460
   PubMed Web of Science ®Google Scholar
• WangJLiuXXieMXieJXiongWXuYIncreased expression of interleukin-18 and its receptor in peripheral blood of patients with chronic obstructive pulmonary diseaseCOPD2012937538122489883
   PubMedGoogle Scholar
• SinghDFoxSMTal-SingerRInduced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokersThorax20116648949521441172
   PubMed Web of Science ®Google Scholar
• MedImmune LLCA to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease Available from: http://clinicaltrials.gov/show/NCT1322594. NLM identifier: NCT1322594Accessed February 21, 2014
   Google Scholar
• LiangSCTanXYLuxenbergDPInterleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesJ Exp Med20062032271227916982811
   PubMed Web of Science ®Google Scholar
• AujlaSJChanYRZhengMIL-22 mediates mucosal host defense against Gram-negative bacterial pneumoniaNat Med20081427528118264110
   PubMed Web of Science ®Google Scholar
• AujlaSJDubinPJKollsJKInterleukin-17 in pulmonary host defenseExp Lung Res20073350751818075825
   PubMed Web of Science ®Google Scholar
• LiangSCLongAJBennettFAn IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitmentJ Immunol20071797791779918025225
   PubMed Web of Science ®Google Scholar
• IwakuraYIshigameHThe IL-23/IL-17 axis in inflammationJ Clin Invest20061161218122216670765
   PubMed Web of Science ®Google Scholar
• WangHPengWWengYImbalance of Th17/Treg cells in mice with chronic cigarette smoke exposureInt Immunopharmacol20121450451223044435
   PubMed Web of Science ®Google Scholar
• PridgeonCBugeonLDonnellyLRegulation of IL-17 in chronic inflammation in the human lungClin Sci (Lond)201112051552421208193
   PubMed Web of Science ®Google Scholar
• Di StefanoACaramoriGCapelliASTAT4 activation in smokers and patients with chronic obstructive pulmonary diseaseEur Respir J200422788515293608
   PubMed Web of Science ®Google Scholar
• LangrishCLMcKenzieBSWilsonNJDe Waal MalefytRKasteleinRACuaDJIL-12 and IL-23: master regulators of innate and adaptive immunityImmunol Rev20042029610515546388
   PubMed Web of Science ®Google Scholar
• OppmannBLesleyRBlomBNovel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12Immunity20001371572511114383
   PubMed Web of Science ®Google Scholar
• LarsenJMSteen-JensenDBLaursenJMDivergent proinflammatory profile of human dendritic cells in response to com-mensal and pathogenic bacteria associated with the airway microbiotaPLoS One20127e3197622363778
   PubMed Web of Science ®Google Scholar
• SethiSMaloneyJGroveLWronaCBerensonCSAirway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200617399199816474030
   PubMed Web of Science ®Google Scholar
• AdcockIMCaramoriGBarnesPJChronic obstructive pulmonary disease and lung cancer: new molecular insightsRespiration20118126528421430413
   PubMed Web of Science ®Google Scholar
• BowmanEPChackerianAACuaDJRationale and safety of anti-interleukin-23 and anti-interleukin-17A therapyCurr Opin Infect Dis20061924525216645485
   PubMed Web of Science ®Google Scholar
• CarriereVRousselLOrtegaNIL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivoProc Natl Acad Sci U S A200710428228717185418
   PubMed Web of Science ®Google Scholar
• SchmitzJOwyangAOldhamEIL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokinesImmunity20052347949016286016
   PubMed Web of Science ®Google Scholar
• BaekkevoldESRoussigneMYamanakaTMolecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venulesAm J Pathol2003163697912819012
   PubMed Web of Science ®Google Scholar
• ObokiKNakaeSMatsumotoKSaitoHIL-33 and airway inflammationAllergy Asthma Immunol Res20113818821461246
   PubMed Web of Science ®Google Scholar
• YagamiAOriharaKMoritaHIL-33 mediates inflammatory responses in human lung tissue cellsJ Immunol20101855743575020926795
   PubMed Web of Science ®Google Scholar
• LeungBPXuDCulshawSMcInnesIBLiewFYA novel therapy of murine collagen-induced arthritis with soluble T1/ST2J Immunol200417314515015210768
   PubMed Web of Science ®Google Scholar
• HackerSLambersCPollreiszAIncreased soluble serum markers caspase-cleaved cytokeratin-18, histones, and ST2 indicate apoptotic turnover and chronic immune response in COPDJ Clin Lab Anal20092337237919927353
   PubMed Web of Science ®Google Scholar
• QiuCLiYLiMAnti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in miceImmunology2013138768223078031
   PubMed Web of Science ®Google Scholar
• ThomasPSYatesDHBarnesPJTumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjectsAm J Respir Crit Care Med199515276807599866
   PubMed Web of Science ®Google Scholar
• BarnesPJCytokine-directed therapies for the treatment of chronic airway diseasesCytokine Growth Factor Rev20031451152214563353
   PubMed Web of Science ®Google Scholar
• ChungKFCytokines as targets in chronic obstructive pulmonary diseaseCurr Drug Targets2006767568116787167
   PubMed Web of Science ®Google Scholar
• ShaoMXNadelJANeutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzymeJ Immunol20051754009401616148149
   PubMed Web of Science ®Google Scholar
• VernooyJHKüçükaycanMJacobsJALocal and systemic inflammation in patients with chronic obstructive pulmonary disease – soluble tumor necrosis factor receptors are increased in sputumAm J Respir Crit Care Med20021661218122412403691
   PubMed Web of Science ®Google Scholar
• Montes de OcaMTorresSHDe SanctisJMataAHernandezNTalamoCSkeletal muscle inflammation and nitric oxide in patients with COPDEur Respir J20052639039716135718
   PubMed Web of Science ®Google Scholar
• LewisMIApoptosis as a potential mechanism of muscle cachexia in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200216643443612186814
   PubMed Web of Science ®Google Scholar
• CaramoriGAdcockIMPharmacology of airway inflammation in asthma and COPDPulm Pharmacol Ther20031624727712877818
   PubMed Web of Science ®Google Scholar
• BarnesPJStockleyRACOPD: current therapeutic interventions and future approachesEur Respir J2005251084110615929966
   PubMed Web of Science ®Google Scholar
• DentenerMACreutzbergECPenningsHJRijkersGTMerckenEWoutersEFEffect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot studyRespiration20087627528218277064
   PubMed Web of Science ®Google Scholar
• van der VaartHKoeterGHPostmaDSKauffmanHFten HackenNHFirst study of infliximab treatment in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200517246546915937294
   PubMed Web of Science ®Google Scholar
• RennardSIFogartyCKelsenSThe safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200717592693417290043
   PubMed Web of Science ®Google Scholar
• AaronSDVandemheenKLMaltaisFTNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trialThorax20136814214823161645
   PubMed Web of Science ®Google Scholar
• DennlerSGoumansMJten DijkePTransforming growth factor beta signal transductionJ Leukoc Biol20027173174011994497
   PubMed Web of Science ®Google Scholar
• AubertJDHayashiSHardsJBaiTRParèPDHoggJCPlatelet-derived growth factor and its receptor in lungs from patients with asthma and chronic airflow obstructionAm J Physiol1994266L655L6638023954
   PubMed Web of Science ®Google Scholar
• de BoerWIvan SchadewijkASontJKTransforming growth factor β1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1998158195119579847291
   PubMed Web of Science ®Google Scholar
• TakizawaHTanakaMTakamiKIncreased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD)Am J Respir Crit Care Med20011631476148311371421
   PubMed Web of Science ®Google Scholar
• SekiyaTOdaTMatsuuraKAkiyamaTTranscriptional regulation of the TGF-beta pseudoreceptor BAMBI by TGF-beta signalingBiochem Biophys Res Commun200432068068415240101
   PubMed Web of Science ®Google Scholar
• OnichtchoukDChenYGDoschRSilencing of TGF-beta signalling by the pseudoreceptor BAMBINature199940148048510519551
   PubMed Web of Science ®Google Scholar
• DrömannDRuppJRohmannKThe TGF-beta-pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzaeRespir Res2010116720513241
   PubMed Web of Science ®Google Scholar
• ScottonCJChambersRCMolecular targets in pulmonary fibrosis: the myofibroblast in focusChest20071321311132117934117
   PubMed Web of Science ®Google Scholar
• LlinàsLPeinadoVIRamon GoñiJSimilar gene expression profiles in smokers and patients with moderate COPDPulm Pharmacol Ther201124324120970515
   PubMed Web of Science ®Google Scholar
• NingWLiCJKaminskiNComprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary diseaseProc Natl Acad Sci U S A2004101148951490015469929
   PubMed Web of Science ®Google Scholar
• KranenburgARWillems-WidyastutiAMooiWJChronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF-1, FGF-2, and FGFR-1J Pathol2005206283815772985
   PubMed Web of Science ®Google Scholar
• KranenburgARDe BoerWIVan KriekenJHEnhanced expression of fibroblast growth factors and receptor FGFR-1 during vascular remodeling in chronic obstructive pulmonary diseaseAm J Respir Cell Mol Biol20022751752512397010
   PubMed Web of Science ®Google Scholar
• AaronSDAngelJBLunauMGranulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116334935511179105
   PubMed Web of Science ®Google Scholar
• BhowmikASeemungalTASapsfordRJWedzichaJARelation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbationsThorax20005511412010639527
   PubMed Web of Science ®Google Scholar
• GompertzSO’BrienCBayleyDLHillSLStockleyRAChanges in bronchial inflammation during acute exacerbations of chronic bronchitisEur Respir J2001171112111911491152
   PubMed Web of Science ®Google Scholar
• KersulALIglesiasARíosAMolecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary diseaseArch Bronconeumol20114717618321454005
   PubMed Web of Science ®Google Scholar
• SethiSMuscarellaKEvansNKlingmanKLGrantBJMurphyTFAirway inflammation and etiology of acute exacerbations of chronic bronchitisChest20001181557156511115440
   PubMed Web of Science ®Google Scholar
• TsoumakidouMTzanakisNChrysofakisGKyriakouDSiafakasNMChanges in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary diseaseRespir Med20059957257915823454
   PubMed Web of Science ®Google Scholar
• Dal NegroRWMichelettoCTognellaSViscontiMGuerrieroMSandriMFA two-stage logistic model based on the measurement of pro-inflammatory cytokines in bronchial secretions for assessing bacterial, viral, and non-infectious origin of COPD exacerbationsCOPD2005271617136956
   PubMedGoogle Scholar
• SinghMLeeSHPorterPHuman rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary diseaseJ Allergy Clin Immunol20101251369137820430426
   PubMed Web of Science ®Google Scholar
• SajjanUGanesanSComstockATElastase- and LPS-exposed mice display altered responses to rhinovirus infectionAm J Physiol Lung Cell Mol Physiol2009297L931L94419748999
   PubMed Web of Science ®Google Scholar
• SaettaMDi StefanoAMaestrelliPAirway eosinophilia in chronic bronchitis during exacerbationsAm J Respir Crit Care Med1994150164616527952628
   PubMed Web of Science ®Google Scholar
• QiuYZhuJBandiVBiopsy neutrophilia, chemokine and receptor gene expression in severe exacerbations of COPDAm J Respir Crit Care Med200316896897512857718
   PubMed Web of Science ®Google Scholar
• SeemungalTHarper-OwenRBhowmikARespiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20011641618162311719299
   PubMed Web of Science ®Google Scholar
• WilkinsonTMHurstJRPereraWRWilksMDonaldsonGCWedzichaJAEffect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPDChest200612931732416478847
   PubMed Web of Science ®Google Scholar
• RolandMBhowmikASapsfordRJSputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary diseaseThorax200156303511120901
   PubMed Web of Science ®Google Scholar
• AlmansaRSanchez-GarciaMHerreroAHost response cytokine signatures in viral and nonviral acute exacerbations of chronic obstructive pulmonary diseaseJ Interferon Cytokine Res20113140941321235417
   PubMed Web of Science ®Google Scholar
• EttingerRKuchenSLipskyPEThe role of IL-21 in regulating B-cell function in health and diseaseImmunol Rev2008223608618613830
   PubMed Web of Science ®Google Scholar
• EdlmayrJNiespodzianaKPopow-KrauppTAntibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisationEur Respir J201137445220530036
   PubMed Web of Science ®Google Scholar
• YerkovichSTHalesBJCarrollMLReduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisationBMC Pulm Med2012123722849333
   PubMed Web of Science ®Google Scholar
• BarkerBRGladstoneMNGillardGOPanasMWLetvinNLCritical role for IL-21 in both primary and memory anti-viral CD8+ T-cell responsesEur J Immunol2010403085309621061439
   PubMed Web of Science ®Google Scholar
• ChenHWangYBaiCWangXAlterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbationJ Proteomics2012752835284322343073
   PubMed Web of Science ®Google Scholar
• HsingCHLiHHHsuYHThe distribution of interleukin-19 in healthy and neoplastic tissueCytokine20084422122818809337
   PubMed Web of Science ®Google Scholar
• KrommidasGKostikasKPapatheodorouGPlasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkersRespir Med2010104404619782551
   PubMed Web of Science ®Google Scholar
• HanMKAgustiACalverleyPMChronic obstructive pulmonary disease phenotypes: the future of COPDAm J Respir Crit Care Med201018259860420522794
   PubMed Web of Science ®Google Scholar
• AgustiACalverleyPMCelliBCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
   PubMed Web of Science ®Google Scholar
• HaldarPBrightlingCEHargadonBMepolizumab and exacerbations of refractory eosinophilic asthmaN Engl J Med2009360973984 Erratum in N Engl J Med 2011;364:58819264686
   PubMed Web of Science ®Google Scholar
• CorrenJLemanskeRFHananiaNALebrikizumab treatment in adults with asthmaN Engl J Med20113651088109821812663
   PubMed Web of Science ®Google Scholar